BREAKING NEWS

BREAKING NEWS

GSK first-quarter revenue beats estimates on shingles vaccine demand

GSK first-quarter revenue beats estimates on shingles vaccine demand
FILE PHOTO: The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera -
Copyright
Loriene Perera(Reuters)
Text size Aa Aa

(Reuters) - GlaxoSmithKline Plc on Wednesday reported a higher-than- expected 6 percent rise in first-quarter revenue, boosted by the British drugmaker's fast-growing shingles vaccine.

GSK's turnover rose to 7.66 billion pounds in the quarter from 7.22 billion pounds a year earlier. Adjusted operating profit was 30.1 pence per share in the quarter.

Analysts on average had expected earnings of 26.1 pence per share and turnover of 7.56 billion pounds, according to a company-provided consensus https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus of 11 analysts.

(Reporting by Pushkala Aripaka and Ankur Banerjee in Bengaluru; Editing by Saumyadeb Chakrabarty)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.